Literature DB >> 12676907

Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?

A-M Martin, P A Kanetsky, B Amirimani, T A Colligon, G Athanasiadis, H A Shih, M R Gerrero, K Calzone, T R Rebbeck, B L Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12676907      PMCID： PMC1735423          DOI： 10.1136/jmg.40.4.e34

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  16 in total

Review 1.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.

Authors:  G Bougeard; S Baert-Desurmont; I Tournier; S Vasseur; C Martin; L Brugieres; A Chompret; B Bressac-de Paillerets; D Stoppa-Lyonnet; C Bonaiti-Pellie; T Frebourg
Journal:  J Med Genet       Date:  2005-10-28       Impact factor: 6.318

3.  Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers.

Authors:  Shenying Fang; Ralf Krahe; Linda L Bachinski; Baili Zhang; Christopher I Amos; Louise C Strong
Journal:  Hum Genet       Date:  2011-06-19       Impact factor: 4.132

4.  Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.

Authors:  Shenying Fang; Ralf Krahe; Guillermina Lozano; Younghun Han; Wei Chen; Sean M Post; Baili Zhang; Charmaine D Wilson; Linda L Bachinski; Louise C Strong; Christopher I Amos
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

5.  A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome.

Authors:  Il-Jin Kim; Hio Chung Kang; Yong Shin; Hye-Won Park; Sang-Geun Jang; Song-Yee Han; Sun-Kyung Lim; Min Ro Lee; Hee Jin Chang; Ja-Lok Ku; Han-Kwang Yang; Jae-Gahb Park
Journal:  J Hum Genet       Date:  2004-09-10       Impact factor: 3.172

6.  A clinical and genetic analysis of multiple primary cancer referrals to genetics services.

Authors:  James Whitworth; Jon Hoffman; Cyril Chapman; Kai Ren Ong; Fiona Lalloo; D Gareth Evans; Eamonn R Maher
Journal:  Eur J Hum Genet       Date:  2014-09-24       Impact factor: 4.246

7.  The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  O M Sinilnikova; A C Antoniou; J Simard; S Healey; M Léoné; D Sinnett; A B Spurdle; J Beesley; X Chen; M H Greene; J T Loud; F Lejbkowicz; G Rennert; S Dishon; I L Andrulis; S M Domchek; K L Nathanson; S Manoukian; P Radice; I Konstantopoulou; I Blanco; A L Laborde; M Durán; A Osorio; J Benitez; U Hamann; F B L Hogervorst; T A M van Os; H J P Gille; S Peock; M Cook; C Luccarini; D G Evans; F Lalloo; R Eeles; G Pichert; R Davidson; T Cole; J Cook; J Paterson; C Brewer; D J Hughes; I Coupier; S Giraud; F Coulet; C Colas; F Soubrier; E Rouleau; I Bièche; R Lidereau; L Demange; C Nogues; H T Lynch; R K Schmutzler; B Versmold; C Engel; A Meindl; N Arnold; C Sutter; H Deissler; D Schaefer; U G Froster; K Aittomäki; H Nevanlinna; L McGuffog; D F Easton; G Chenevix-Trench; D Stoppa-Lyonnet
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

8.  Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer.

Authors:  Yaxuan Liu; Olga Axell; Tom van Leeuwen; Robert Konrat; Pedram Kharaziha; Catharina Larsson; Anthony P H Wright; Svetlana Bajalica-Lagercrantz
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

9.  Inherited and acquired alterations in development of breast cancer.

Authors:  Piera Rizzolo; Valentina Silvestri; Mario Falchetti; Laura Ottini
Journal:  Appl Clin Genet       Date:  2011-11-14

10.  Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.

Authors:  Sandra Costa; Daniela Pinto; Deolinda Pereira; Helena Rodrigues; Jorge Cameselle-Teijeiro; Rui Medeiros; Fernando Schmitt
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.